Update on 2009 pandemic influenza A (H1N1) virus

Tanaffos

Volumn 9, Issue 1, 2010, Pages 8-14

  Marjani, Majid ^a   Baghaei, Parvaneh ^a   Tabarsi, Payam ^a   Mansouri, Seyed Davood ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOMODULATING AGENT; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS A H1N1 VACCINE; LIVE VACCINE; MACROLIDE; METICILLIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PERAMIVIR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; STEROID; TACROLIMUS; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; ZANAMIVIR;

ADULT RESPIRATORY DISTRESS SYNDROME; APPLICATION SITE PAIN; APPLICATION SITE REACTION; APPLICATION SITE SWELLING; BACTERIAL PNEUMONIA; BRONCHITIS; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; FATIGUE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXEMIA; IMMUNE DEFICIENCY; INCUBATION TIME; INFECTION CONTROL; INFECTION SENSITIVITY; INFLUENZA A (H1N1); LABORATORY TEST; LOWER RESPIRATORY TRACT; MORBID OBESITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYALGIA; NONHUMAN; PANDEMIC INFLUENZA; PATIENT CARE; PNEUMONIA; RECOMMENDED DRUG DOSE; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SECONDARY INFECTION; SYMPTOM; THORAX RADIOGRAPHY; VACCINE PRODUCTION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 77955291236     PISSN: 17350344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009; 45 (3): 169-73.
2. Calisher CH. Swine flu. Croat Med J 2009; 50 (4): 412-5.
3. Zimmer SM, Burke DS. Historical perspective--Emergence of influenza A (H1N1) viruses. N Engl J Med 2009; 361 (3): 279-85.
4. Petrosillo N, Di Bella S, Drapeau CM, Grilli E. The novel influenza A (H1N1) virus pandemic: An update. Ann Thorac Med 2009; 4 (4): 163-72.
5. Kumar D, Humar A. Pandemic influenza and its implications for transplantation. Am J Transplant 2006; 6 (7): 1512-7.
6. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361 (7): 674-9.
7. Satpathy HK, Lindsay M, Kawwass JF. Novel H1N1 virus infection and pregnancy. Postgrad Med 2009; 121 (6): 106-12.
8. Kingsford C, Nagarajan N, Salzberg SL. 2009 Swine-origin influenza A (H1N1) resembles previous influenza isolates. PLoS One 2009; 4 (7): e6402.
9. World health organization. Pandemic (H1N1) 2009-update 81. http://www.who.int/csr/don/2009_12_30/en/index.html. Last accessed 27/12/09
10. World health organization. What is the situation in the WHO Eastern Mediterranean Region? http:// www.emro. who. int/ csr/h1n1/h1n1_update.htm. Last accessed 27/12/09
11. Gordon SM. Update on 2009 pandemic influenza A (H1N1) virus. Cleve Clin J Med 2009; 76 (10): 577-82.
12. World health organization. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. http://www.who.int/csr/resources/publications/swineflu/clini cal_management/en/index.html. Last accessed 27/12/09
13. Centers for Disease Control and Prevention. Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel. http://www.flu.gov/professional/hospital/infectioncontrolgui dance.html. Last accessed 27/12/09
14. Machado AA. How to prevent, recognize and diagnose infection with the swine-origin Influenza A (H1N1) virus in humans. J Bras Pneumol 2009; 35 (5): 464-9.
15. World health organization. Clinical Management of Pandemic (H1N1) 2009 Virus Infection, Interim Guidance from Expert Consultation 17 September 2009. http://www. emro.who.int/csr/h1n1/pdf/clinical_management_guidelines. pdf. Last accessed 27/12/09
16. Barlow GD; BSAC Council. Swine flu and antibiotics. J Antimicrob Chemother 2009; 64 (5): 889-94.
17. Wenzel RP, Edmond MB. Preparing for 2009 H1N1 Influenza. N Engl J Med 2009; 361 (20): 1991-3.
18. World health organization. Pandemic influenza A (H1N1) 2009: considerations for tuberculosis care services. http://www.who.int/csr/resources/publications/swineflu/h1n1_tb/en/index.html. Last accessed 27/12/09
19. Centers for Disease Control and Prevention. Updated Interim Recommendations: Special Considerations for Clinicians Regarding 2009 H1N1 Influenza in Severely Immunosuppressed Patients. http://www. cdc.gov/ h1n1flu/ immunosuppression/index.htm. Last accessed 27/12/09
20. Gordon SM. Update on 2009 pandemic influenza A (H1N1) virus. Cleve Clin J Med. 2009 Oct;76(10):577-82.
21. Ciblak MA, Albayrak N, Odabas Y, Basak Altas A, Kanturvardar M, Hasoksuz M, et al. Cases of influenza A(H1N1)v reported in Turkey, May-July 2009. Euro Surveill 2009; 14 (32). pii: 19304.
22. Kumar D, Morris MI, Kotton CN, Fischer SA, Michaels MG, Allen U, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010; 10 (1): 18-25.
23. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361 (7): 680-9.
24. Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 361 (25): 2493.
25. World health organization. Considerations on influenza A(H1N1) and HIV infection. http:// www. who. int/ csr/ resources/publications/swineflu/AH1N1HIV/en/index.html. Last accessed 27/12/09
26. Wiwanitkit V. Finding a new drug and vaccine for emerging swine flu: What is the concept? Biologics 2009; 3: 377-83.
27. World health organization. Oseltamivir resistance in immunocompromised hospital patients. http:// www. who. int/csr/disease/swineflu/notes/briefing_20091202/en/index.ht ml. Last accessed 27/12/09
28. Centers for Disease Control and Prevention (CDC). Neurologic complications associated with novel influenza A (H1N1) virus infection in children-Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep 2009; 58 (28): 773-8.
29. Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, Galas FR, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010; 181 (1): 72-9.
30. Gupta A, Ignatius A, Khaira A, Agarwal SK. Swine influenza: nephrologist's perspective. Iran J Kidney Dis 2009; 3 (3): 175-6.
31. Rahier JF, Yazdanpanah Y, Viget N, Travis S, Colombel JF. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2010; 31 (1): 5-10.
32. World health organization. Considerations on influenza A(H1N1) and HIV infection. http://www. who.int/csr/ resources/publications/swineflu/AH1N1HIV/en/index.html. Last accessed 27/12/09
33. World health organization. Infection prevention and control during health care for confirmed, probable, or suspected cases of pandemic (H1N1) 2009 virus infection and influenza-like illnesses. http://www. who.int/ csr/resources/ publications/swineflu/swineinfinfcont/en/index.html. Last accessed 27/12/09
34. Johnson DF, Druce JD, Birch C, Grayson ML. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis 2009; 49 (2): 275-7.
35. Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009; 302 (17): 1865-71.
36. Centers for Disease Control and Prevention. Questions and answers regarding respiratory protection for preventing 2009 H1N1 influenza among healthcare personnel. http://www. cdc.gov/h1n1flu/guidelines_infection_control_qa.htm. Last accessed 27/12/09
37. World health organization. Statement from WHO Global Advisory Committee on Vaccine Safety about the safety profile of pandemic influenza A (H1N1) 2009 vaccines. http://www.who.int/csr/resources/publications/swineflu/gacv s_statement_20091218/en/index.html. Last accessed 27/12/09
38. World health organization. Safety of pandemic vaccines. http://www.who.int/csr/disease/swineflu/notes/briefing_20091119/en/index .html.Lastaccessed 27/12/09
39. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361 (25): 2405-13.
40. Dopp JM, Wiegert NA, Moran JJ, Francois ML, Radford KL, Thomas H, et al. Effect of annual influenza immunization on antibody response in lung transplant patients. Prog Transplant 2009; 19 (2): 153-9.